Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,824.05
+36.50 (2.04%)
At close: Jul 13, 2026
Ipca Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 462,579 | 406,231 | 381,038 | 313,934 | 205,589 | 270,385 | |
Market Cap Growth | 33.85% | 6.61% | 21.38% | 52.70% | -23.96% | 11.96% |
Enterprise Value | 473,313 | 420,860 | 398,201 | 338,588 | 200,771 | 264,496 |
Last Close Price | 1824.05 | 1603.00 | 1499.22 | 1233.03 | 805.39 | 1049.86 |
PE Ratio | 40.54 | 35.60 | 51.65 | 57.36 | 43.62 | 30.58 |
PS Ratio | 4.79 | 4.21 | 4.26 | 4.07 | 3.29 | 4.64 |
PB Ratio | 4.86 | 4.26 | 4.54 | 4.06 | 3.48 | 4.88 |
P/TBV Ratio | 5.88 | 5.16 | 5.65 | 5.15 | 3.64 | 5.14 |
P/FCF Ratio | 95.18 | 83.58 | 69.82 | 58.86 | 66.03 | 71.70 |
P/OCF Ratio | 40.51 | 35.57 | 28.84 | 33.23 | 25.51 | 31.58 |
EV/Sales Ratio | 4.91 | 4.36 | 4.45 | 4.39 | 3.21 | 4.54 |
EV/EBITDA Ratio | 23.35 | 21.27 | 23.89 | 26.78 | 21.22 | 20.75 |
EV/EBIT Ratio | 29.26 | 26.97 | 30.70 | 36.35 | 28.55 | 24.98 |
EV/FCF Ratio | 97.39 | 86.59 | 72.96 | 63.48 | 64.49 | 70.14 |
Debt / Equity Ratio | 0.09 | 0.09 | 0.16 | 0.19 | 0.25 | 0.15 |
Debt / EBITDA Ratio | 0.41 | 0.41 | 0.81 | 1.12 | 1.55 | 0.63 |
Debt / FCF Ratio | 1.66 | 1.66 | 2.50 | 2.70 | 4.76 | 2.14 |
Net Debt / Equity Ratio | -0.04 | -0.04 | 0.03 | 0.08 | -0.12 | -0.10 |
Net Debt / EBITDA Ratio | -0.20 | -0.20 | 0.16 | 0.46 | -0.73 | -0.43 |
Net Debt / FCF Ratio | -0.80 | -0.80 | 0.47 | 1.10 | -2.23 | -1.47 |
Asset Turnover | 0.80 | 0.80 | 0.78 | 0.78 | 0.77 | 0.85 |
Inventory Turnover | 1.07 | 1.07 | 1.23 | 1.35 | 1.40 | 1.28 |
Quick Ratio | 1.39 | 1.39 | 1.36 | 1.17 | 1.86 | 1.70 |
Current Ratio | 2.76 | 2.76 | 2.63 | 2.35 | 2.87 | 3.04 |
Return on Equity (ROE) | 13.22% | 13.22% | 9.74% | 7.67% | 8.36% | 17.35% |
Return on Assets (ROA) | 8.08% | 8.08% | 7.09% | 5.90% | 5.41% | 9.67% |
Return on Invested Capital (ROIC) | 13.10% | 13.28% | 10.64% | 8.61% | 9.01% | 18.36% |
Return on Capital Employed (ROCE) | 15.50% | 15.50% | 13.80% | 10.70% | 10.30% | 17.20% |
Earnings Yield | 2.47% | 2.81% | 1.94% | 1.74% | 2.29% | 3.27% |
FCF Yield | 1.05% | 1.20% | 1.43% | 1.70% | 1.51% | 1.40% |
Dividend Yield | 0.34% | 0.37% | 0.27% | 0.32% | 0.50% | 0.38% |
Payout Ratio | 4.59% | 4.59% | 13.76% | 9.27% | 21.53% | 11.48% |
Buyback Yield / Dilution | 0.00% | 0.00% | - | - | - | -0.17% |
Total Shareholder Return | 0.34% | 0.38% | 0.27% | 0.32% | 0.50% | 0.21% |